thiazoles has been researched along with Learning Disabilities in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Onaizi, M; Barbash, S; Bekenstein, U; Fahnestock, M; Haberman, N; Hanin, G; Kish, MT; Kolisnyk, B; Prado, MAM; Prado, VF; Soreq, H; Soreq, L; Souza da Silva, J; Ule, J | 1 |
| Danysz, W; Dekundy, A; Gravius, A; Morè, L; Nagel, J; Pietraszek, M | 1 |
| Enomoto, T; Horisawa, T; Ishibashi, T; Ishiyama, T; Nishikawa, H; Taiji, M; Toma, S | 1 |
| Alves, CB; Alves, MP; Ianiski, FR; Luchese, C; Pinton, S; Rhoden, CR; Roman, SS; Souza, AC | 1 |
| Cunningham, CL; Groblewski, PA | 1 |
| Altamirano, L; Cools, R; D'Esposito, M | 1 |
| Enomoto, T; Ishibashi, T; Ishiyama, T; Ito, A; Tokuda, K; Toma, S | 1 |
| Chiba, T; Haganuma, A; Kikuchi, H; Mori, K; Murakami, S; Nakagawasai, O; Nakahata, N; Obara, Y; Oshima, Y; Tadano, T | 1 |
8 other study(ies) available for thiazoles and Learning Disabilities
| Article | Year |
|---|---|
Cholinergic Surveillance over Hippocampal RNA Metabolism and Alzheimer's-Like Pathology.
Topics: Acetylcholine; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Cells, Cultured; Disease Models, Animal; Embryo, Mammalian; Enzyme Inhibitors; Gene Expression Regulation; Glycogen Synthase Kinase 3; Hippocampus; Humans; Learning Disabilities; Mice; Mice, Inbred C57BL; Mice, Transgenic; RNA; Thiazoles; Thyroid Nuclear Factor 1; Urea; Vesicular Acetylcholine Transport Proteins | 2017 |
Investigation on tolerance development to subchronic blockade of mGluR5 in models of learning, anxiety, and levodopa-induced dyskinesia in rats.
Topics: Animals; Antiparkinson Agents; Anxiety Disorders; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Tolerance; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Glutamic Acid; Learning Disabilities; Levodopa; Male; Maze Learning; Memory Disorders; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Synaptic Transmission; Thiazoles | 2008 |
The effects of selective antagonists of serotonin 5-HT7 and 5-HT1A receptors on MK-801-induced impairment of learning and memory in the passive avoidance and Morris water maze tests in rats: mechanistic implications for the beneficial effects of the novel
Topics: Animals; Avoidance Learning; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Isoindoles; Learning Disabilities; Lurasidone Hydrochloride; Male; Maze Learning; Memory Disorders; Rats; Rats, Wistar; Reaction Time; Receptor, Serotonin, 5-HT1A; Receptors, Serotonin; Serotonin Agents; Thiazoles; Time Factors | 2011 |
Protective effect of meloxicam-loaded nanocapsules against amyloid-β peptide-induced damage in mice.
Topics: Amyloid beta-Peptides; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Avoidance Learning; Behavior, Animal; Body Weight; Brain; Catalase; Disease Models, Animal; Exploratory Behavior; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Glutathione Transferase; Learning Disabilities; Male; Maze Learning; Meloxicam; Memory Disorders; Mice; Nanocapsules; Peptide Fragments; Superoxide Dismutase; Thiazines; Thiazoles; Time Factors | 2012 |
Repeated microinjections into the medial prefrontal cortex (mPFC) impair extinction of conditioned place preference in mice.
Topics: Analysis of Variance; Anesthetics, Local; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bupivacaine; Central Nervous System Depressants; Conditioning, Operant; Disease Models, Animal; Ethanol; Extinction, Psychological; Learning Disabilities; Male; Meloxicam; Mice; Mice, Inbred DBA; Microinjections; Prefrontal Cortex; Thiazines; Thiazoles; Time Factors | 2012 |
Reversal learning in Parkinson's disease depends on medication status and outcome valence.
Topics: Aged; Analysis of Variance; Antiparkinson Agents; Benzothiazoles; Case-Control Studies; Female; Humans; Learning Disabilities; Male; Middle Aged; Neuropsychological Tests; Outcome Assessment, Health Care; Parkinson Disease; Pramipexole; Reversal Learning; Thiazoles | 2006 |
Lurasidone reverses MK-801-induced impairment of learning and memory in the Morris water maze and radial-arm maze tests in rats.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Behavior, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Interactions; Isoindoles; Learning Disabilities; Lurasidone Hydrochloride; Male; Maze Learning; Memory Disorders; Rats; Rats, Wistar; Reaction Time; Swimming; Thiazoles | 2008 |
5,19-cyclo-9beta,10xi-androstane-3,17-dione promotes neurotrophic factor biosynthesis in 1321N1 human astrocytoma cells and improves passive avoidance learning impairment.
Topics: Androsterone; Animals; Astrocytoma; Avoidance Learning; Behavior, Animal; Cell Differentiation; Cell Line; Cyclic AMP; Diterpenes; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Humans; Inositol Phosphates; Learning Disabilities; Male; Mice; Nerve Growth Factor; Neurites; PC12 Cells; Proto-Oncogene Mas; Rats; Scopolamine; Tetrazolium Salts; Thiazoles | 2007 |